Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben van Calster

Showing results (81-90 of 224) with videos related to

Pageof 23
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 18, 2014
Integrating pretreatment diffusion weighted MRI into a multivariable prognostic model for head and neck squamous cell carcinomaMaarten Lambrecht, Ben Van Calster, Vincent Vandecaveye, et al.
Statistics in Medicine|July 22, 2014
Net reclassification improvement and integrated discrimination improvement require calibrated models: relevance from a marker and model perspectiveMaarten J G Leening, Ewout W Steyerberg, Ben Van Calster, et al.
International Journal of Cardiology|June 2, 2018
An ordinal prediction model of the diagnosis of non-obstructive coronary artery and multi-vessel disease in the CARDIIGAN cohortMichael Edlinger, Jakob Dörler, Hanno Ulmer, et al.
Obstetrics and Gynecology|October 22, 2011
Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assayDirk Timmerman, Ben Van Calster, Ignace Vergote, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|January 15, 2013
Evaluation of markers and risk prediction models: overview of relationships between NRI and decision-analytic measuresBen Van Calster, Andrew J Vickers, Michael J Pencina, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 28, 2012
Role of neoadjuvant chemotherapy in the management of stage IIIC-IV ovarian cancer: survey results from the members of the European Society of Gynecological OncologySarah Cornelis, Ben Van Calster, Frederic Amant, et al.
Diagnostic and Prognostic Research|March 22, 2021
Adaptive sample size determination for the development of clinical prediction modelsEvangelia Christodoulou, Maarten van Smeden, Michael Edlinger, et al.
European Journal of Epidemiology|October 12, 2012
Assessing the discriminative ability of risk models for more than two outcome categoriesBen Van Calster, Yvonne Vergouwe, Caspar W N Looman, et al.
Statistics in Medicine|January 27, 2025
The Harms of Class Imbalance Corrections for Machine Learning Based Prediction Models: A Simulation StudyAlex Carriero, Kim Luijken, Anne de Hond, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 8, 2011
Wilms tumor gene 1 (WT1) is a prognostic marker in high-grade uterine sarcomaAn Coosemans, Ben Van Calster, Godelieve Verbist, et al.
Pageof 23

Showing results (81-90 of 224) with videos related to

Sort By:
Pageof 23
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 18, 2014
Integrating pretreatment diffusion weighted MRI into a multivariable prognostic model for head and neck squamous cell carcinomaMaarten Lambrecht, Ben Van Calster, Vincent Vandecaveye, et al.
Statistics in Medicine|July 22, 2014
Net reclassification improvement and integrated discrimination improvement require calibrated models: relevance from a marker and model perspectiveMaarten J G Leening, Ewout W Steyerberg, Ben Van Calster, et al.
International Journal of Cardiology|June 2, 2018
An ordinal prediction model of the diagnosis of non-obstructive coronary artery and multi-vessel disease in the CARDIIGAN cohortMichael Edlinger, Jakob Dörler, Hanno Ulmer, et al.
Obstetrics and Gynecology|October 22, 2011
Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assayDirk Timmerman, Ben Van Calster, Ignace Vergote, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|January 15, 2013
Evaluation of markers and risk prediction models: overview of relationships between NRI and decision-analytic measuresBen Van Calster, Andrew J Vickers, Michael J Pencina, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 28, 2012
Role of neoadjuvant chemotherapy in the management of stage IIIC-IV ovarian cancer: survey results from the members of the European Society of Gynecological OncologySarah Cornelis, Ben Van Calster, Frederic Amant, et al.
Diagnostic and Prognostic Research|March 22, 2021
Adaptive sample size determination for the development of clinical prediction modelsEvangelia Christodoulou, Maarten van Smeden, Michael Edlinger, et al.
European Journal of Epidemiology|October 12, 2012
Assessing the discriminative ability of risk models for more than two outcome categoriesBen Van Calster, Yvonne Vergouwe, Caspar W N Looman, et al.
Statistics in Medicine|January 27, 2025
The Harms of Class Imbalance Corrections for Machine Learning Based Prediction Models: A Simulation StudyAlex Carriero, Kim Luijken, Anne de Hond, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 8, 2011
Wilms tumor gene 1 (WT1) is a prognostic marker in high-grade uterine sarcomaAn Coosemans, Ben Van Calster, Godelieve Verbist, et al.
Pageof 23